Skip to main content


Highlights: Assessing the results of the diagnostic quality assurance pilot

Since 2016, a group of committed multistakeholders representing public and private payers, labs, providers (pathologists and oncologists), patient organizations, industry (diagnostic and drug developers), and others have supported the design and implementation of the Diagnostic Quality Assurance Pilot. The pilot helps to ensure that molecular diagnostics provide clinicians with consistent and correct answers, regardless of which lab conducts the test and which diagnostic platform the lab uses. In April of 2019, the pilot’s steering committee, which includes representatives from Friends of Cancer Research, the College of American Pathologists, Palmetto GBA, Blue Cross Blue Shield Association, Amgen, and others, along with liaisons from FDA, CMS, and NCI, will convene in Washington, DC to discuss the pilot’s results.

                                                                                                                                       Specifically, the pilot has engineered and disseminated reference samples and a bioinformatics challenges for labs to assess whether their appropriately validated tests can achieve diagnostic performance comparable to an FDA-approved companion diagnostic (CDx). For the pilot, the test case at hand is a CDx for a targeted cancer therapy. The pilot aims to understand how this approach can better standardize and compare diagnostics used to select patients for targeted therapies in cancer treatment. During the April meeting, the pilot steering committee and representatives from its scientific technical working group will address the pilot’s outcomes, implications, and follow-on communications. For more background on the pilot, please visit the pilot’s website or Tapestry’s case study on the pilot’s implementation to date. 

Tapestry In The News

The European Corporate Governance Institute (ECGI), in a paper entitled Shareholder Collaboration published in August 2018, recently quoted Tapestry's work saying:

"Engagement does not just occur at the individual company level. Both investors and issuers are participating in a growing number of private initiatives aimed at promoting board-shareholder collaboration on a variety of issues and, in particular, corporate governance matters. 

One of the first such initiatives was the “Shareholder-Director Exchange Program” (SDX), a private organization established in 2014 by representatives of major US corporations and big institutional investors like BlackRock and Vanguard. The SDX’s aim is promoting a voluntary template for healthy relations between shareholders and boards as well as regular and successful engagement on matters such as corporate governance, management changes, and long-term plans. Importantly, in defining successful engagement, the SDX’s protocol includes as essential “each party’s willingness to listen carefully to one another and to take action in response to valid concerns.” That is, each party’s willingness to collaborate with the other is seen as crucial within the SDX framework."

Upcoming meetings

Southwest Audit Committee Network

May 2019, Houston, TX



West Audit Committee Network - South Chapter

May 2019, Santa Monica, CA



Southeast Audit Committe Network

May 2019, Atlanta, GA



Diagnostic Quality Assurance Pilot Steering Committee

May 2019, Washington, DC


Insurance Governance Leadership Network 

May 2019, London, UK


Audit Committee Leadership Summit

June 2019, New York City, NY



Welcome To Tapestry

Senior Associate

We're pleased to announce the addition of Anna Seleny to the Tapestry team! Prior to joining Tapestry, Anna was a professor of international politics and political economy. She taught at Princeton University, Tufts’ Fletcher School of Law & Diplomacy, and the St. Gallen International School of Business in Switzerland, in both traditional and executive education programs. Her research and publications have focused on the comparative international political economy of Europe, Eastern Europe and the post-socialist world, and Latin America. 

Recent Publications

Board oversight of risk

European Audit Committee Leadership Network, March 2019

Read more here


Oversight of corporate culture

European Audit Committee Leadership Network, March 2019

Read more here

Owning, using, and protecting data: opportunities and risks for leading insurers

Insurance Governance Leadership Network, January 2019

Read more here

A board guide to the Securities and Exchange Commission’s current priorities 

Lead Director Network, 
December 2018

Read more here

Reinventing financial services

Financial Services Leadership Summit,
December 2018

Read more here

Discussions on gender equity and CEO assessment

Compensation Committee Leadership Network, November 2018

Read more here